Clinical Trial Update: Prevention of Retinal Non-perfusion in Central Retinal Vein Occlusion by Hydroxycarbamide Treatment. [Phase 2]

View source ↗

Summary

An update on a Phase 2 trial evaluating hydroxycarbamide to prevent retinal non-perfusion in non-ischemic central retinal vein occlusion. The study is sponsored…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Retinal Vein Occlusion

Drugs mentioned

• Hydroxycarbamide (hydroxycarbamide)

Snippet

Sponsor: Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts | Conditions: Central Retinal Vein Occlusion, Non-Ischemic | Phase 2 | Status: UNKNOWN